Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Small molecule combats cancer-causing KRAS protein at last

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 575, 294-295 (2019)



  1. Sanchez-Vega, F. et al. Cell 173, 321–337 (2018).

    Article  PubMed  Google Scholar 

  2. Canon, J. et al. Nature (2019).

    Article  Google Scholar 

  3. Lu, S., Jang, H., Nussinov, R. & Zhang, J. Sci. Rep. 6, 21949 (2016).

    Article  PubMed  Google Scholar 

  4. AACR Project GENIE Consortium. Cancer Discov. 7, 818–831 (2017).

    Article  PubMed  Google Scholar 

  5. Herbst, R. S., Morgensztern, D. & Boshoff, C. Nature 553, 446–454 (2018).

    Article  PubMed  Google Scholar 

  6. Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A. & Shokat, K. M. Nature 503, 548–551 (2013).

    Article  PubMed  Google Scholar 

  7. Janes, M. R. et al. Cell 172, 578–589 (2018).

    Article  PubMed  Google Scholar 

  8. Patricelli, M. P. et al. Cancer Discov. 6, 316–329 (2016).

    Article  PubMed  Google Scholar 

  9. Fakih, M., O’Neil, B. & Price, T. J. J. Clin. Oncol. 37 (suppl.), 3003 (2019).

    Article  Google Scholar 

  10. Govindan, R. et al. Ann. Oncol. 30 (Suppl. 5), mdz244.008 (2019).

    Article  Google Scholar 

  11. Hallin, J. et al. Cancer Discov. (2019).

    Article  Google Scholar 

Download references

Competing Interests

R.S.H. has received honoraria from the following:

Consulting: Abbvie Pharmaceuticals, ARMO Biosciences, AstraZeneca, Biodesix, Bolt Biotherapeutics, Bristol-Myers Squibb, Eli Lilly and Company, EMD Serrano, Genentech/Roche, Genmab, Halozyme, Heat Biologics, IMAB Biopharma, Immunocore, Infinity Pharmaceuticals, Loxo Oncology, Merck and Company, Midas Health Analytics, Nektar, Neon Therapeutics, NextCure, Novartis, Pfizer, Sanofi, Seattle Genetics, Shire PLC, Spectrum Pharmaceuticals, Symphogen, Takeda, Tesaro, Tocagen.

Research support: AstraZeneca, Eli Lilly and Company, Merck and Company.

He is a member of the board of directors (non-executive/ independent) for Junshi Pharmaceuticals.


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links